Showing 1 - 6 of 6
We examine the effect of the Jumpstart Our Business Startups (JOBS) Act on biotech startups, who conduct almost 40% of IPOs since 2012. Reduced compliance costs encourage innovation capital formation as biotech IPO volume increases 200% and proceeds rise by 30%. After the JOBS Act, biotech...
Persistent link: https://www.econbiz.de/10012829465
Persistent link: https://www.econbiz.de/10014319911
Persistent link: https://www.econbiz.de/10002098496
Persistent link: https://www.econbiz.de/10002174015
Persistent link: https://www.econbiz.de/10002174038
Persistent link: https://www.econbiz.de/10002009976